Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
Provided By GlobeNewswire
Last update: Jul 2, 2024
IRVINE, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company’s management team will be hosting one-on-one meetings at the Leerink Partners Therapeutics Forum: I&I and Metabolism, on July 9, 2024, in Boston, MA.
